Nirogam India Private Limited Pharmaceutical Export Profile — India (DGFT 2022–2026)

Name: Nirogam India Private Limited Pharmaceutical Export Portfolio Dataset — 2 Products, $230.5K FOB USD, India (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Nirogam India Private Limited — Pharmaceutical Exporter Profile (2026) | 2 Products, $230.5K Trade | TransData Nexus

Nirogam India Private Limited

Indian Pharmaceutical Exporter · Ayurvedic & Herbal Products Specialist · $230.5K Total Trade · DGFT Verified

Nirogam India Private Limited is an Indian pharmaceutical exporter with a total trade value of $230.5K across 2 products in 1 therapeutic categories. Based on 92 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Extract ($216.2K), Bhasma ($14.2K), .

Nirogam India Private Limited — Export Portfolio & Destination Treemap

Nirogam India Private Limited pharmaceutical export portfolio — 2 products across 1 therapeutic categories. Source: Indian Customs (DGFT).

Who is Nirogam India Private Limited? — Company Overview & Market Position

Nirogam India Private Limited is a privately held company incorporated on May 17, 2012, in New Delhi, India. The company operates in the e-commerce sector, specializing in the retail of wellness, organic, and Ayurvedic products. Its Corporate Identification Number (CIN) is U51397DL2012PTC235985. The authorized capital stands at ₹2.5 million, with a paid-up capital of ₹0.7 million. The registered office is located at 55 2nd Floor Lane No. 2, Westend Marg, Saidullajab, Near Saket Metro Station, New Delhi, Delhi, 110030.

The company's leadership comprises two directors: Neha Aggarwal and Puneet Aggarwal, both appointed on May 17, 2012. As of January 11, 2026, Nirogam India Private Limited employs between 11 to 50 individuals.

What Does Nirogam India Private Limited Export? — Product Portfolio Analysis

Top Products by Export Value

1Extract$216.2K 2Bhasma$14.2K

Product Portfolio — Top 2 by Export Value

Nirogam India Private Limited exports 2 pharmaceutical products across 1 therapeutic categories.

#	Product	Category	Export Value	Shipments	Market Share	Rank
1	Extract	Ayurvedic & Herbal Products	$216.2K	79	1.8%	14
2	Bhasma	Ayurvedic & Herbal Products	$14.2K	13	3.4%	8

Nirogam India Private Limited exports 2 pharmaceutical products across 1 therapeutic categories with a total export value of $230.5K. The top category is Ayurvedic & Herbal Products (100.0% of portfolio), indicating a concentrated portfolio with the top 5 products accounting for 100.0% of total export value.

Nirogam India Private Limited — Corporate Profile & Information

Headquarters, ownership, manufacturing facilities, and key leadership

1Corporate Overview

2Manufacturing Facilities

Nirogam India Private Limited operates manufacturing facilities in New Delhi and Faridabad, Haryana. The New Delhi facility is situated at 55 2nd Floor Lane No. 2, Westend Marg, Saidullajab, Near Saket Metro Station, New Delhi, Delhi, 110030. The Faridabad facility is located at F-32, DLF Centre Point, Sector 11, Main Mathura Road, Faridabad, Haryana, 121006. Specific details regarding production capacities and specializations are not publicly disclosed.

3Key Leadership

The key leadership of Nirogam India Private Limited includes:

Neha Aggarwal: Director, appointed on May 17, 2012.

Puneet Aggarwal: Director, appointed on May 17, 2012.

TransData Nexus Research · Government registries, company filings, regulatory databasesMar 2026

Where Does Nirogam India Private Limited Export? — Destination Intelligence

Regulated market presence, emerging market penetration, and geographic strategy

1Regulated Markets

Nirogam India Private Limited's export activities are primarily focused on Ayurvedic and herbal products, with a total export value of $230,000 USD across 92 shipments. The top two exported products are Extract ($216,000, Rank #14, 1.8% market share) and Bhasma ($14,000, Rank #8, 3.4% market share). These products fall under the Ayurvedic & Herbal Products category, which constitutes 100% of the company's export portfolio. The company does not hold a market leader position in any specific category. The portfolio is highly concentrated, with the top five products accounting for 100% of the exports.

2Emerging Markets

Nirogam India Private Limited's export data does not specify its presence in emerging markets such as Africa, Latin America, or Southeast Asia. The company's focus appears to be on Ayurvedic and herbal products, which may have varying levels of demand in these regions. Without specific data, it is challenging to assess the company's penetration in these markets or its WHO prequalification status.

3Geographic Strategy

The company's export strategy is highly concentrated, with the top five products accounting for 100% of the exports. This indicates a lack of diversification in its product offerings. The absence of data on geographic distribution makes it difficult to assess the company's diversification in terms of market reach. A concentrated portfolio may expose the company to risks associated with market fluctuations and regulatory changes in its primary markets.

Nirogam India Private Limited — Manufacturing & Regulatory Profile

FDA status, WHO-GMP certification, EU GMP compliance, and regulatory track record

1FDA Status

Specific information regarding Nirogam India Private Limited's FDA facility registrations, approved Abbreviated New Drug Applications (ANDAs), Drug Master File (DMF) filings, and inspection history is not publicly available. The company's focus on Ayurvedic and herbal products may influence its regulatory interactions with the FDA. Without detailed data, it is challenging to assess the company's compliance with FDA regulations and its standing in the U.S. market.

2WHO & EU GMP

There is no publicly available information regarding Nirogam India Private Limited's WHO prequalification status, EU Good Manufacturing Practice (GMP) certificates, or European Directorate for the Quality of Medicines & HealthCare (EDQM) status. The company's emphasis on Ayurvedic and herbal products may impact its eligibility for these certifications. Without specific data, it is difficult to evaluate the company's adherence to international quality standards.

3CDSCO & Indian Regulatory

Nirogam India Private Limited — Competitive Positioning Among Indian Pharma Exporters

Market share comparison, key differentiators, and strategic analysis

1Competitive Landscape

Nirogam India Private Limited operates in the Ayurvedic and herbal products sector, which is characterized by a diverse range of competitors. Specific market share comparisons and head-to-head analyses are not available. The company's focus on e-commerce platforms for wellness, organic, and Ayurvedic products positions it in competition with other online retailers in the same domain. However, without detailed market data, it is challenging to provide a comprehensive competitive analysis.

2Key Differentiators

Nirogam India Private Limited's key differentiators include its specialization in Ayurvedic and herbal products, catering to consumers seeking traditional wellness solutions. The company's e-commerce platform offers a range of wellness, organic, and Ayurvedic products, positioning it as a niche player in the market. However, without detailed information on product formulations, sourcing practices, and customer engagement strategies, it is difficult to identify additional unique strengths or competitive advantages.

3Strategic Position

Nirogam India Private Limited's strategic direction appears to be focused on the e-commerce retail of Ayurvedic and herbal products. The company's portfolio is highly concentrated, with the top five products accounting for 100% of exports, indicating a specialized approach. Without information on future plans, it is challenging to assess the company's intentions regarding generics, specialty products, biosimilars, or Contract Development and Manufacturing Organization (CDMO) services.

Buyer Due Diligence Brief — Evaluating Nirogam India Private Limited as a Supplier

Track record assessment, certifications to verify, and pre-order checks

1Supplier Assessment

Nirogam India Private Limited's track record in terms of export volume and consistency is not publicly detailed. The company's focus on Ayurvedic and herbal products suggests a commitment to traditional wellness solutions. However, without specific data on supplier relationships, production consistency, and quality control measures, it is difficult to assess the company's reliability as a supplier.

2Certifications to Verify

Importers considering Nirogam India Private Limited as a supplier should verify the following certifications:

FDA Facility Registration: To ensure compliance with U.S. regulations.

WHO-GMP Certification: To confirm adherence to international manufacturing standards.

EU GMP Certification: To verify compliance with European manufacturing practices.

Frequently Asked Questions — Nirogam India Private Limited

How many pharmaceutical products does Nirogam India Private Limited export from India?

Nirogam India Private Limited exports 2 pharmaceutical products across 1 therapeutic categories. The top exports are Extract ($216.2K), Bhasma ($14.2K). Total export value is $230.5K.

What is Nirogam India Private Limited's total pharmaceutical export value?

Nirogam India Private Limited's total pharmaceutical export value is $230.5K, based on 92 verified shipments recorded in Indian Customs (DGFT) data.

What therapeutic categories does Nirogam India Private Limited cover?

Nirogam India Private Limited exports across 1 therapeutic categories. The largest are Ayurvedic & Herbal Products (100.0%, 2 products).

Get Full Nirogam India Private Limited Export Intelligence

Access shipment-level details, pricing data, buyer connections, product breakdown, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify manufacturer licensing, GMP certification, and export registration with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports per product category. For current shipment-level data, contact TransData Nexus.